Using generative AI, MIT researchers design compounds that can kill drug-resistant bacteria
MIT researchers used AI to design millions of novel compounds, identifying two antibiotics effective against drug-resistant gonorrhoea and MRSA amid a global health crisis causing over one million deaths annually.
- Researchers at the Massachusetts Institute of Technology used generative AI to design millions of new compounds against drug-resistant bacteria.
- The top candidates discovered are structurally different from existing antibiotics and may disrupt bacterial cell membranes in novel ways.
- The compounds need years of refinement and clinical trials before they can be prescribed.
- The MIT team believes AI could lead to a 'second golden age' in antibiotic discovery.
48 Articles
48 Articles
Researchers at the Massachusetts Institute of Technology (MIT) have developed two new potential antibiotics using artificial intelligence (AI).
We will have to wait another year or two for clinical trials.
AI designs antibiotics to fight drug-resistant superbugs
An artificial intelligence model designed new antibiotics to fight gonorrhea and mRSA superbugs. The overuse of antibiotics can create resistance, when the drugs kill off all but those bacteria most capable of surviving the treatment. It has led to the rise of some bugs that are all but impossible to treat with existing antibiotics, raising fears that modern medicine and surgery — reliant on antibiotics — could collapse, given that few new antib…
Coverage Details
Bias Distribution
- 48% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium